Microarray Scanners Market Is Expected To Offer Substantial Growth Opportunities, Reaching $1.5 Billion By 2030
What Is The Expected Valuation Of The Microarray Scanners Market In The Upcoming Years, And How Quickly Is It Set To Grow?
The microarray scanners market size has grown strongly in recent years. It will grow from $1 billion in 2025 to $1.08 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to expansion of genomics research activities, growth in academic and research funding, increasing use of microarray technologies, rising demand for gene expression analysis, advancements in fluorescence detection methods.
The microarray scanners market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing adoption of precision medicine research, rising investments in biotechnology and pharmaceutical R&D, expansion of large-scale genomic studies, growing integration of ai-driven data analysis, increasing demand for high-throughput research tools. Major trends in the forecast period include increasing adoption of high-resolution fluorescence scanners, rising use in genomic and proteomic research, growing integration with data analysis software, expansion of automated sample processing, enhanced focus on multiplex detection.
Claim Your Free Report Sample Today:
Which Major Drivers Are Accelerating Expansion Within The Microarray Scanners Market?
The rising prevalence of chronic diseases is expected to propel the growth of the microarray scanner market going forward. Chronic disease is a form of illness that lasts three months or more and can deteriorate with time. Microarray scanners can assess gene expression patterns, allowing researchers to investigate the molecular mechanisms underlying chronic diseases and discover potential biomarkers for diagnosis, prognosis, and treatment. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, there will be 142.66 million people with chronic diseases worldwide by the year 2050. Therefore, the rising prevalence of chronic diseases is driving the growth of the microarray scanner market.
Which Segments Are Expected To Shape The Future Direction Of The Microarray Scanners Market?
The microarray scanners market covered in this report is segmented –
1) By Product Type: Fluorescence Microarray Scanners, Charge-Coupled Devices Microarray Scanners, Colorimetric Microarray Scanners, Other Product Types
2) By Application: Gene Expression, Drug Discovery, Other Applications
3) By End User: Hospitals, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Academic And Research Institutes
Subsegments:
1) By Fluorescence Microarray Scanners: Laser Scanners, Multispectral Scanners
2) By Charge-Coupled Devices (CCD) Microarray Scanners: Standard CCD Scanners, High-Resolution CCD Scanners
3) By Colorimetric Microarray Scanners: Slide Scanners, Digital Colorimetric Scanners
4) By Other Product Types: Hybrid Scanners, Custom Or Specialized Microarray Scanners
Which Strategic Trends Are Likely To Impact Competitive Positioning In The Microarray Scanners Market?
Major companies operating in the microarray scanners market are developing innovative products, such as an advanced microarray platform, to sustain their position in the market. An advanced microarray platform is a high-throughput technology that enables simultaneous analysis of thousands of genes, proteins, or biomarkers on a single chip with enhanced sensitivity, specificity, and data accuracy. For instance, in June 2023, MARGenomics private ltd., a Spain-based company, launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform that marks a significant development in the microarray technology space. This platform is notable for being the first in Europe and the United States to receive regulatory approval for diagnostic purposes, indicating its potential impact on clinical diagnostics and research. With its ability to provide high-resolution genomic data, it is poised to enhance personalized medicine approaches in various therapeutic areas.
Who Are The Companies Setting The Competitive Benchmark In The Microarray Scanners Market?
Major companies operating in the microarray scanners market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE Healthcare Life Sciences, Hitachi High-Tech Corporation, Innopsys Inc., PerkinElmer Inc., VWR International LLC, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Tecan Group AG, Huron Technologies International Inc., Miltenyi Biotec B.V. & Co. KG, Luminex Corporation, Molecular Devices LLC, CapitalBio Technology Inc., Berthold Technologies GmbH & Co. KG, RayBiotech Inc., Scienion AG, Oxford Gene Technology IP Limited, Applied Microarrays Inc., Arrayit Corporation
Get Your In-Depth Microarray Scanners Market Report Now:
Which Region Currently Accounts For The Largest Share Of The Microarray Scanners Market?
North America was the largest region in the microarray scanners market in 2025. The regions covered in the microarray scanners market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment